Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
24 September, 2025
Prostate Cancer Month: Focus on the TROG Genitourinary Working Party
To mark Prostate Cancer Month in September, we asked
24 September, 2025
TROG members and staff celebrate World Radiotherapy Awareness Day
LATEST NEWS: 24 September 2025 TROG Cancer Research staff